2,190
Views
12
CrossRef citations to date
0
Altmetric
Technology Evaluation

Eluvia™ peripheral stent system for the treatment of peripheral lesions above the knee

Pages 1639-1644 | Received 08 Jun 2016, Accepted 24 Aug 2016, Published online: 05 Oct 2016

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Stefanos Giannopoulos & Ehrin J. Armstrong. (2019) Newly approved devices for endovascular treatment of femoropopliteal disease: a review of clinical evidence. Expert Review of Cardiovascular Therapy 17:10, pages 729-740.
Read now

Articles from other publishers (11)

Alexandre Pouhin, Raphaël Coscas, Valentin Crespy, Olivia Poupardin, Jean-Paul Pais-De-Barros, Olivier Bouchot, Alain Bernard & Eric Steinmetz. (2023) Comparative Evaluation of Two Paclitaxel-Coated Stents in an Experimental Setting. Journal of Endovascular Therapy.
Crossref
Andrew Holden, Yann Gouëffic, William A. Gray, Elizabeth J. Davis, Ido Weinberg & Michael R. Jaff. (2023) Hypoechoic Halo Imaging Findings Following Femoropopliteal Artery Stent Implantation. JACC: Cardiovascular Interventions 16:13, pages 1654-1664.
Crossref
Lyo Min Kwon, Saebeom Hur, Hwan Jun Jae, Seung-Kee Min, Sang-Il Min, Sanghyun Ahn & Ahram Han. (2021) One-Year Outcomes of Two Different Paclitaxel-Eluting Stents (Zilver PTX and Eluvia) for Trans-Atlantic Inter-Society Consensus Document (TASC) C/D Obstructive Femoropopliteal Lesions. Iranian Journal of Radiology 19:1.
Crossref
Steven Kum, Jetty Ipema, Eline Huizing, Yih K Tan, Darryl Lim, Ian YH Lok, Constantijn EVB Hazenberg & Çağdaş Ünlü. (2021) Outcomes of the paclitaxel-eluting Eluvia stent for long femoropopliteal lesions in Asian patients with predominantly chronic limb-threatening ischemia. Vascular Medicine 26:3, pages 267-272.
Crossref
Yoshimitsu Soga, Masahiko Fujihara, Osamu Iida, Daizo Kawasaki, Keisuke Hirano, Hiroyoshi Yokoi, Akira Miyamoto, Kimihiko Kichikawa, Masato Nakamura, Takao Ohki, Juan Diaz-Cartelle, William A. Gray & Stefan Müller-Hülsbeck. (2019) Japanese Patients Treated in the IMPERIAL Randomized Trial Comparing Eluvia and Zilver PTX Stents. CardioVascular and Interventional Radiology 43:2, pages 215-222.
Crossref
Konstantin Kuznetsov, Alena Stepanova, Ren Kvon, Timothy Douglas, Nikita Kuznetsov, Vera Chernonosova, Ivan Zaporozhchenko, Maria Kharkova, Irina Romanova, Andrey Karpenko & Pavel Laktionov. (2018) Electrospun Produced 3D Matrices for Covering of Vascular Stents: Paclitaxel Release Depending on Fiber Structure and Composition of the External Environment. Materials 11:11, pages 2176.
Crossref
Leslie Mertz. (2018) Opening Act: New Multidisciplinary Approaches Yield Thinner, Stronger, Better Stents. IEEE Pulse 9:6, pages 15-19.
Crossref
Stefan Müller-Hülsbeck, Silke Hopf-Jensen, Koen Keirse, Thomas Zeller, Herman Schroë, Juan Diaz-Cartelle & William A Gray. (2018) Eluvia drug-eluting vascular stent system for the treatment of symptomatic femoropopliteal lesions. Future Cardiology 14:3, pages 207-213.
Crossref
Ali F. AbuRahma. (2018) When Are Endovascular and Open Bypass Treatments Preferred for Femoropopliteal Occlusive Disease?. Annals of Vascular Diseases 11:1, pages 25-40.
Crossref
S. Müller-Hülsbeck. 2018. Periphere arterielle Interventionen. Periphere arterielle Interventionen 209 215 .
Stefan Müller-Hülsbeck, Koen Keirse, Thomas Zeller, Herman Schroë & Juan Diaz-Cartelle. (2017) Long-Term Results from the MAJESTIC Trial of the Eluvia Paclitaxel-Eluting Stent for Femoropopliteal Treatment: 3-Year Follow-up. CardioVascular and Interventional Radiology 40:12, pages 1832-1838.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.